ACTSI Newsletter
|
Trouble viewing this email? Click here
to view on the web.
| |
| |  | 
ACTSI Weekly eRoundup
June 16, 2017
|
| |
| |  | | As part of the Southeastern Shared Health Research Informatics Network (SHRINE), ACTSI is collaborating with Clinical and Translational Science Award (CTSA) Hubs including the University of Alabama at Birmingham, University of Arkansas, University of Kentucky, and Medical University of South Carolina, to federate available data at each institution for assessment of clinical trial feasibility, participant recruitment, and comparative effectiveness ... | | | | Read More | | |
| |
| | | | This funding mechanism is intended to stimulate new, collaborative research in regenerative medicine among Georgia Tech, Emory, and UGA investigators. The seed grant team must have a minimum of two investigators and must have an equal partnership of faculty from two of the participating institutions with budgets split between the universities as equally as possible. This funding mechanism may support collaborative projects at earlier stages of development in the high risk, high yield category or projects with a high potential for clinical or industry translation. | | | | Read More | | |
| |
| | | | The FY17 PRORP challenges the scientific community to address the most significant gaps in care for the leading burden of injury and loss of fitness for military duty by funding innovative, high-impact, clinically relevant research to advance optimal treatment and rehabilitation from neuromusculoskeletal injuries (excluding spinal cord injuries) sustained during combat or combat-related activities. | | | | Read More | | |
| |
| | | | The award is intended to support studies that will make an important contribution toward research and/or patient care for a disease or condition related to at least one of the vast and varied congressionally directed FY17 PRMRP Topic Areas. A Technology/Therapeutic Development Award is also available. | | | | Read More | | |
| |
| | | | The American Association for Cancer Research (AACR) is accepting applications designed to provide new treatment options for cancers with high unmet medical need, encourage innovation and translation of ideas from basic research into novel drugs, and foster collaborations between excellent academic groups and the pharmaceutical industry. | | | | Read More | | |
| |
| | | | The GGACT cooperative, a collaboration between Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and the University of California Los Angeles, was established to support investigators in rapidly translating complex gene and cell therapies to early phase, investigator-initiated clinical trials by providing expertise in protocol development and implementation, trial and data management, and regulatory affairs, as well as utilizing established infrastructure for preclinical models of disease and testing, process development, and GMP vector production and cellular manufacturing. Eligible applicants must be faculty at a CTSA institution that has an established pediatric stem cell transplant program. | | | | Read More | | |
| |
| | | | The DMDRP Investigator-Initiated Research Award (IIRA) supports translational research that will accelerate the movement of promising ideas in Duchenne research into clinical applications. Career Development Award also available. | | | | Read More | | |
| |
| | | | The vision is to decrease the clinical impact of NF. Toward this end, the NFRP seeks to support innovative, high-impact research that will foster new directions for and address neglected issues in NF research; sponsor multidisciplinary and multi-institutional collaborations that will bring new perspectives to the field; promote translational and clinical studies to move promising ideas from bench to bedside; and develop a balanced portfolio of meritorious research related to all aspects of NF1, NF2, and schwannomatosis. New Investigator Award also available. | | | | Read More | | |
| |
| | | | The Emory School of Medicine Office of Postdoctoral Education offers the course designed specifically for Postdocs and Medical Research Fellows. The course has both an online component and four required classroom sessions for the eight topics covered. | | | | Read More | | |
| |
| | | | | CPTR is a multidisciplinary, innovative program that provides pre-doctoral or postdoctoral trainees with the expertise and experience to translate fundamental biomedical scientific discoveries into treatments that will benefit human health. Sixteen credits of didactic training focused on translational research in Emory’s Laney Graduate School of Emory University are required to complete the certificate program. Emory faculty and postdocs may ... | | | | Read More | | |
|
| |
| | | | This program constitutes a national network of mentors and scholars, in contrast to K12 programs that are based solely at a single applicant institution. | | | | Read More | | |
| |
| | | | | Faculty and postdocs are welcome to enroll in a fall semester course which is part of the curriculum in the Georgia CTSA’s Certificate Program in Translational Research in the Laney Graduate School. Tuition awards are not available, but faculty and postdocs at Emory may be eligible for the Emory Courtesy Scholarship if employed at least one year. This is a semester-long course which meets on Mondays from 3:00-4:50 p.m. from September 10 until ... | | | | Read More | | |
|
| |
| | | | | Faculty and postdocs are welcome to enroll in a fall semester course which is part of the curriculum in the Georgia CTSA’s Master of Science in Clinical Research degree program in the Laney Graduate School. Tuition awards are not available, but Emory faculty and postdocs may be eligible for the Emory Courtesy Scholarship which would cover tuition for the course. This is a semester-long course which meets on Thursdays, from 10:00 to 11:50 am. ... | | | | Read More | | |
|
| |
| | | | While the majority of SBIR/STTR awards go to startups with fewer than 10 employees, it doesn't mean you have to do all the work yourself. The smaller you are, the fewer capabilities you have in-house; you must rely on outside partners to enhance your competencies to be successful. | | | | Read More | | |
| |
| | | | This seed grant competition is an opportunity for the scientific and business community including entrepreneurs, clinicians, scientists, businesses, academic researchers and medical and engineering graduate and undergraduate students, to develop and commercialize a pediatric medical device. The proposal should be directed towards development of a commercializable product, not research of a scientific concept. | | | | Read More | | |
| |
| | | | The U.S. Department of Agriculture, National Institute of Food and Agriculture is accepting grant applications for the RHSE program. Proposals are expected to be community-based, outreach education programs, such as those conducted through Human Science extension outreach. | | | | Read More | | |
| |
| | | | The President's Council on Fitness, Sports & Nutrition (PCFSN) recently launched the #0to60 Challenge! For the next 60 days, rise to the challenge by committing to be active your way. You can increase your daily physical activity or make delicious and nutritious meals. This #0to60 Challenge is for everyone ¿ fitness beginners, weekend warriors, athletes, kids, and families. The Challenge was designed to inspire all Americans to accelerate their journey to a healthy lifestyle by going #0to60 every day. | | | | Read More | | |
| |
| | | | The U.S. Deaf community - a minority group of 500,000 people who use American Sign Language - is one of the most understudied populations in biomedical research. These barriers have contributed to a long history of mistreatment of Deaf people in the research world, resulting in their mistrust of researchers and reluctance to participate in biomedical research studies. In response to these issues, we will lead Deaf ACCESS: Adapting Consent through Community Engagement and State-of-the-art Simulation.
Speakers will summarize developments in compliance and security issues, FDA guidelines for pre-market and post-market management of cybersecurity, as well as FDA rules regarding software for medical devices and software as a medical device (SaMD).
| | | | Read More | | |
| |
| | | | A practical, hands-on workshop series focused on the challenge of commercializing bioscience technologies hosted by Georgia Bio. | | | | Read More | | |
| |
| | | | This webinar will center around the Michigan Institute for Clinical & Health Research's Recruitment & Retention Toolkit and the use of HelpJuice as its platform. HelpJuice is a knowledge based software that allows for a searchable format to assist with the identification of resources quickly and easily for study teams. | | | | Read More | | |
| |
| | | | | Dr. Gary Gibbons, Director of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH), will serve as the plenary speaker. Other content during the full-day conference will include Demographics, Disparities, and Data in Cardiovascular Health; Predictive Health Data Science: Big Data Science for Longitudinal Health Monitoring; High Performance Clinical Informatics: Embedding Data Science within Healthcare Systems; ... | | | | Read More | | |
|
| |
| | | The Georgia CTSA Clinical Research Centers (GCRCs) and Emory Medical Laboratory announce a new course for Emory University and Healthcare employees. The two-day course will be held on August 18 and 25. Thereafter, students will be assigned to clinical areas for hands-on training and competency validation. Contact: Kateisha.dowdell@emoryhealthcare.org ... | | | | Read More | | |
| |
| | | | Join Georgia Bio at Clearside Biomedical's new offices in Alpharetta. Clearside Bio is a late-stage clinical ophthalmic biopharmaceutical company that envisions a world without blindness. BioBash serves as a gathering place for discussion of issues affecting our growing industry and facilitating mutually beneficial relationships through exchanges of information, ideas and support. | | | | Read More | | |
| |
| | | | This conference will be of special interest to quality assurance and regulatory affairs professionals, industry, as well as biodesign innovators, device manufacturers, and academic professionals. | | | | Read More | | |
| |
| For more information on ACTSI, please visit
www.actsi.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
actsi@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
actsi@emory.edu.
Please include the following citation in any publications resulting from direct or indirect ACTSI support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2 TR000455 and TL1 Trainees should also list TL1 TR000456. |
| |
|
